IL-1 is required for tumor invasiveness and angiogenesis

Proceedings of the National Academy of Sciences of the United States of America

Volumn 100, Issue 5, 2003, Pages 2645-2650

  Voronov, Elena ^a   Shouval, Dror S ^a   Krelin, Yakov ^a   Cagnano, Emanuela ^a   Benharroch, Daniel ^a   Iwakura, Yoichiro ^b   Dinarello, Charles A ^c   Apte, Ron N ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b UNIVERSITY OF TOKYO   (Japan)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1; MATRIGEL; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; RECOMBINANT INTERLEUKIN 1ALPHA;

ANGIOGENESIS; ANIMAL CELL; ANIMAL MODEL; ARTICLE; BREAST ADENOCARCINOMA; CANCER INVASION; KNOCKOUT MOUSE; MELANOMA CELL; MICROVASCULATURE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; TUMOR CELL CULTURE; TUMOR IMMUNOLOGY;

ADENOCARCINOMA; ANIMALS; CELLS, CULTURED; COCULTURE TECHNIQUES; COLLAGEN; DRUG COMBINATIONS; HUMANS; INTERLEUKIN-1; LAMININ; MACROPHAGES; MACROPHAGES, PERITONEAL; MAMMARY NEOPLASMS, ANIMAL; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROCIRCULATION; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; PROTEOGLYCANS; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; RECOMBINANT PROTEINS; TIME FACTORS; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA;

EID: 0037418208     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0437939100     Document Type: Article

References (49)

1. Dinarello, C. A. (1996) Blood 87, 2095-2147.
2. Folkman, J. (1971) N. Engl. J. Med. 285, 404-405.
3. Folkman, J. (1990) Cancer Metastasis Rev. 9, 171-174.
4. Holmgren, L., O'Reilly, M. S. & Folkman, J. (1995) Nat. Med. 1, 149-153.
5. Folkman, J. & D'Amore, P. A. (1996) Cell 87, 1153-1155.
6. Hanahan, D. & Folkman, J. (1996) Cell 86, 353-364.
7. Carmeliet, P. & Jain, R. K. (2000) Nature 407, 249-257.
8. Liotta, L. A. & Kohn, E. C. (2001) Nature 411, 375-379.
9. Chirivi, R. G., Garofalo, A., Padura, I. M., Mantovani, A. & Giavazzi, R. (1993) Cancer Res. 53, 5051-5054.
10. Vidal-Vanaclocha, F., Amezaga, C., Asumendi, A., Kaplanski, G. & Dinarello, C. A. (1994) Cancer Res. 54, 2667-2672.
11. Chirivi, R. G., Chiodoni, C., Musiani, P., Garofalo, A., Bernasconi, S., Colombo, M. P. & Giavazzi, R. (1996) Int. J. Cancer 67, 856-863.
12. McKenzie, R. C., Oran, A., Dinarello, C. A. & Sauder, D. N. (1996) Anticancer Res. 16, 437-441.
13. Vidal-Vanaclocha, F., Alvarez, A., Asumendi, A., Urcelay, B., Tonino, P. & Dinarello, C. A. (1996) J. Natl. Cancer Inst. 88, 198-205.
14. Anasagasti, M. J., Alvarez, A., Martin, J. J., Mendoza, L. & Vidal-Vanaclocha, F. (1997) Hepatology 25, 840-846.
15. Apte, R. N., Dvorkin, T., Song, X., Fima, E., Krelin, Y., Yulevitch, A., Gurfinkel, R., Werman, A., White, R, M., Argov, S., et al. (2000) Adv. Exp. Med. Biol. 479, 277-288.
16. Apte, R. N. & Voronov, E. (2002) Semin. Cancer Biol. 12, 277-290.
17. Vidal-Vanaclocha, F., Fantuzzi, G., Mendoza, L., Fuentes, A. M., Anasagasti, M. J., Martin, J., Carrascal, T., Walsh, P., Reznikov, L. L., Kim, S. H., et al. (2000) Proc. Natl. Acad. Sci. USA 97, 734-739.
18. Mantovani, A. & Dejana, E. (1989) Immunol. Today 10, 370-375.
19. Meager, A. (1999) J. Immunol. Methods 227, 197-198.
20. Porgador, A., Tzehoval, E., Katz, A., Vadai, E., Revel, M., Feldman, M., & Eisenbach, L. (1992) Cancer Res. 52, 3679-3686.
21. Fu, Y. X., Watson, G., Jimenez, J. J., Wang, Y. & Lopez, D. M. (1990) Cancer Res. 50, 227-234.
22. Zheng, H., Fletcher, D., Kozak, W., Jiang, M., Hofmann, K. J., Conn, C. A., Soszynski, D., Grabiec, C., Trumbauer, M. E., Shaw, A., et al. (1995) Immunity 3, 9-19.
23. Fantuzzi, G., Zheng, H., Faggioni, R., Benigni, F. Ghezzi, P., Sipe, J. D., Shaw, A. R. & Dinarello, C. A. (1996) J. Immunol. 157, 291-296.
24. Horai, R., Asano, M., Sudo, K., Kanuka, H., Suzuki, M., Nishihara, M., Takahashi, M. & Iwakura, Y. (1998) J. Exp. Med. 187, 1463-1475.
25. Fridman, R., Kibbey, M. C., Royce, L. S., Zain, M., Sweeney, M., Jicha, D. L., Yannelli, J. R., Martin, G. R. & Kleinman, H. K. (1991). J. Natl. Cancer Inst. 83, 769-774.
26. Sehested, M. & Hou-Jensen, K. (1981) Virchows Arch. A Pathol. Anat. Histol. 391, 217-225.
27. Weidner, N., Semple, J. P., Welch, W. R. & Folkman, J. (1991) N. Engl. J. Med. 324, 1-8.
28. Voronov, E., Weinstein, Y., Benharroch, D., Cagnano, E., Ofir, R., Dobkin, M., White, R. M., Zoller, M., Barak, V., Segal, S. & Apte, R. N. (1999) Cancer Res. 59, 1029-1035.
29. Douvdevani, A., Huleihel, M., Zoller, M., Segal, S. & Apte, R. N. (1992) Int. J. Cancer 51, 822-830.
30. Apte, R. N., Douvdevani, A., Zoller, M., White, R. M., Dvorkin, T., Shimoni, N., Fima, E., Hacham, M., Huleihel, M., Benharroch, D., et al. (1993) Immunol. Lett. 39, 45-52.
31. Saijo, Y., Tanaka, M., Miki, M., Usui, K., Suzuki, T., Maemondo, M., Hong, X., Tazawa, R., Kikuchi, T., Matsushima, K. & Nukiwa, T. (2002) J. Immunol. 169, 469-475.
32. Carmeliet, P., Dor, Y., Herbert, J. M., Fukumura, D., Brusselmans, K., Dewerchin, M., Neeman, M., Bono, F., Abramovitch, R., Maxwell, P., et al. (1998) Nature 394, 485-490.
33. Keshet, E. & Ben-Sasson, S. A. (1999) J. Clin. Invest. 104, 1497-1501.
34. Thornton, R. D., Lane, P., Borghaei, R. C., Pease, E. A., Caro, J. & Mochan, E. (2000) Biochem. J. 350, Part 1, 307-312.
35. Haddad, J. J. (2002) Eur. Cytokine Network 13, 250-260.
36. Nozaki, S., Sledge, G. W., Jr., & Nakshatri, H. (2000) Biochem. Biophys. Res. Commun. 275, 60-62.
37. Neufeld, G., Kessler, O., Vadasz, Z. & Gluzman-Poltorak, Z. (2001) Surg. Oncol. Clin. North Am. 10, 339-56, ix.
38. Dor, Y., Djonov, V., Abramovitch, R., Itin, A., Fishman, G. I., Carmeliet, P., Goelman, G. & Keshet, E. (2002). EMBO J. 21, 1939-1947.
39. Harris, A. L. (2002) Nat. Rev. Cancer 2, 38-47.
40. O'Reilly, M. S., Holmgren, L., Shing, Y., Chen, C., Rosenthal, R. A., Moses, M., Lane, W. S., Cao, Y., Sage, E. H. & Folkman, J. (1994) Cell 79, 315-328.
41. O'Reilly, M. S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W. S., Flynn, E., Birkhead, J. R., Olsen, B. R. & Folkman, J. (1997) Cell 88, 277-285.
42. Slaton, J. W., Perrotte, P., Inoue, K., Dinney, C. P. & Fidler, I. J. (1999) Clin. Cancer Res. 5, 2726-2734.
43. Kleiner, D. E. & Stetler-Stevenson, W. G. (1999) Cancer Chemother. Pharmacol. 43, Suppl., S42-S51.
44. Zucker, S., Cao, J. & Chen, W. T. (2000) Oncogene 19, 6642-6650.
45. Vlodavsky, I. & Friedmann, Y. (2001) J. Clin. Invest. 108, 341-347.
46. Thun, M. J., Henley, S. J. & Patrono, C. (2002) J. Natl. Cancer Inst. 94, 252-266.
47. Scatena, M. & Giachelli, C. (2002) Trends Cardiovasc. Med. 12, 83-88.
48. Huang, S., Pettaway, C. A., Uehara, H., Bucana, C. D. & Fidler, I. J. (2001) Oncogene 20, 4188-4197.
49. Coxon, A., Bolon, B., Estrada, J., Kaufman, S., Scully, S., Rattan, A., Duryea, D., Hu, Y. L., Rex, K., Pacheco, E., et al. (2002) Arthritis Rheum. 46, 2604-2612.